Press Releases

Accuray's Image-Guided CyberKnife Stereotactic Radiosurgery System is Most Accurate in the World Sunnyvale, California, Feb 19, 2004 - Accuray Incorporated announced today that the CyberKnife® Stereotactic Radiosurgery System has proven to be the most accurate, real-time, image-guided radiosurgery system in the world, with the updated manufacturer specification of 0.95 mm "total clinical accuracy." This measurement incorporates all sources of error in comprehensive end-to-end testing, thus providing the overall system accuracy one could expect of treatments in the clinical setting. Read More »
Accuray Receives Japanese Regulatory Clearance for its CyberKnife II Stereotactic Radiosurgery System Sunnyvale, California, January 14, 2004 - Accuray Incorporated, the world leader in image-guided full-body radiosurgery, is pleased to announce that it has received Shonin (regulatory) approval in Japan for the CyberKnife® Stereotactic Radiosurgery System. The CyberKnife System will be marketed as the CyberKnife II System. Read More »
Introducing the TomoTherapy Hi-Art System 2.0 December 23, 2003 - TomoTherapy has recently received FDA clearance for the TomoTherapy Hi-Art System 2.0. The new release, which will begin shipping in January 2004, offers significant advances in both treatment planning and delivery. Read More »
TomoTherapy Incorporated Earns Key Regulatory Certification April 25, 2003 - TomoTherapy Incorporated is proud to announce we have earned our ISO 9001, ISO 13485, and EN 46001 quality system certification. Read More »
TomoTherapy Founders Win Ernst & Young Award February 7, 2002 - T. 'Rock' MackieTomoTherapy co-founders Dr. Thomas "Rock" Mackie and Mr. Paul J. Reckwerdt have been named Emerging Entrepreneurs of the Year for the Wisconsin region in the prestigious 2002 Ernst & Young Entrepreneur of the Year awards program. Read More »
TomoTherapy Inc. Gains FDA 510(k) Clearance for Hi-Art System July 2, 2002 - TomoTherapy has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its helical tomotherapy system. Read More »

Pages